Deutsch
A A A
DE
Bereichsnavigation

Previous
Disclosure of voting rights | 11/04/2013

RHÖN-KLINIKUM AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution


RHÖN-KLINIKUM AG

04.11.2013 16:30

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.




Notification according to section 26 para. 1 WpHG

B. Braun Melsungen Aktiengesellschaft, Melsungen, Germany notified us
pursuant to section 25 para. 1 WpHG and pursuant to section 25a para. 1
WpHG of the following:

1) B. Braun Melsungen Aktiengesellschaft, Melsungen, Germany notified us
pursuant to section 25 para. 1 WpHG of the following:
On 31 October 2013, B. Braun Melsungen Aktiengesellschaft exceeded the
threshold of 5% of the voting rights in RHÖN-KLINIKUM Aktiengesellschaft,
Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, B.
Braun Melsungen Aktiengesellschaft held 6.02% of the voting rights in
RHÖN-KLINIKUM Aktiengesellschaft arising from 8,322,288 voting rights.
From these voting rights a proportion of 3,002% (equals 4,150,000 voting
rights) is based on voting rights pursuant to sections 21, 22 WpHG and a
proportion of 3.02% (equals 4,172,288 voting rights) is based on (financial
/ other) instruments pursuant to section 25 WpHG. From the voting rights
based on instruments pursuant to section 25 WpHG a proportion of 0% (equals
0 voting rights) is held indirectly. The exercise period of the instruments
pursuant to section 25 WpHG is October 31, 2013 until November 6, 2013.

2) B. Braun Melsungen Aktiengesellschaft, Melsungen, Germany notified us
pursuant to section 25a para. 1 WpHG of the following:
On 31 October 2013, B. Braun Melsungen Aktiengesellschaft exceeded the
threshold of 5% of the voting rights in RHÖN-KLINIKUM Aktiengesellschaft,
Schlossplatz 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, B.
Braun Melsungen Aktiengesllschaft held 6.02% of the voting rights in
RHÖN-KLINIKUM Aktiengesellschaft arising from 8,323,288 voting rights.
From these voting rights a proportion of 3,002% (equals 4,150,000 voting
rights) is based on voting rights pursuant to sections 21, 22 WpHG and a
proportion of 3.02% (equals 4,172,288 voting rights) is based on (financial
/ other) instruments pursuant to section 25 WpHG. From the voting rights
based on instruments pursuant to section 25 WpHG a proportion of 0% (equals
0 voting rights) is held indirectly.
In addition, a proportion of 0.001% (equals 1,000 voting rights) is based
on (financial/other) instruments pursuant to section 25a WpHG. From the
voting rights based on instruments pursuant to section 25a WpHG a
proportion of 0% (equals 0 voting rights) is held indirectly. The
instruments pursuant to section 25a WpHG are sold put options ('Verkaufte
Put-Optionen') with expiration date 22 December 2014.

Bad Neustadt a.d. Saale, November 4, 2013

The Board of Management
________________________________________________________________

Dr. Kai G. Klinger
Head of Investor Relations
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Phone: +49 9771 65 - 1318
Fax: +49 9771 99 - 1736



04.11.2013 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de




Language: English
Company: RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a.d.Saale
Germany
Internet: www.rhoen-klinikum-ag.com

End of Announcement DGAP News-Service